Supportive Care for Patients Newly Diagnosed With Lung Cancer
Palliative Care Interventions for Outpatients With Newly Diagnosed Lung Cancer
1 other identifier
interventional
41
1 country
1
Brief Summary
The aims of this project are to assess the feasibility of recruiting patients and delivering a nurse-led telephone based palliative care intervention for patients with newly diagnosed lung cancer and to assess if among patients with newly diagnosed lung cancer, the investigators can estimate the effect of a nurse-led telephone based palliative care intervention on quality-of-life, symptom burden and patient satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lung-cancer
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2013
CompletedFirst Posted
Study publicly available on registry
June 21, 2013
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedResults Posted
Study results publicly available
January 31, 2017
CompletedJanuary 31, 2017
December 1, 2016
1.8 years
June 18, 2013
October 7, 2016
December 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change From Baseline in Functional Assessment of Cancer Therapy-Lung Total Outcome Index Score at 3 Months
Patient Quality of Life including symptoms as measured by the FACT-L (Functional Assessment of Cancer Therapy-Lung Scale). The FACT-L outcome measure reported is the mean change in the TOI subscale (Total Outcome Index) of the instrument, computed as the differences between final and baseline visit scores. The TOI subscale range is 0-84 with a higher score indicating a better quality of life.
Baseline and 3 months
Secondary Outcomes (3)
Change From Baseline in Patient Satisfaction of Care at 3 Months
Baseline and 3 months
Change in Baseline Quality of Clinician Communication at 3 Months
Baseline and 3 months
Change From Baseline in Clinician Knowledge of Patient Preferences at 3 Months
Baseline and 3 months
Study Arms (2)
Intervention
EXPERIMENTALThis is a 3 month nurse-led telephone based program integrating palliative care into usual oncologic care for patients diagnosed within 2 months of any type and stage of lung cancer.
Usual Care
NO INTERVENTIONSubjects randomized to usual care will receive medical oncology, radiation oncology, pulmonary, CT surgery as indicated by the type of cancer. At the completion of 3 months of usual care, subjects are invited to join the intervention arm.
Interventions
Care delivered by a nurse including symptom assessment and management, patient education on lung cancer and treatment options , discussion and communication about preferences for care, psychosocial assessment including referrals to ancillary services such as social services and spiritual care as requested by the patient.
Eligibility Criteria
You may qualify if:
- Patients diagnosed at the Puget Sound Health Care System with a primary diagnosis of lung cancer,
- any cell type or stage,
- diagnosed within 8 weeks of study enrollment.
- Must have telephone access,
- ability of understand English and
- provide informed consent.
You may not qualify if:
- Patients not eligible to participate in the study include those who are inpatients prior to randomization,
- those who are under the care of palliative care or hospice at the time of randomization,
- those who have severe mental health disorders,
- those who are unable to speak directly with the nurse over the telephone,
- or those that have the inability to provide informed consent. Investigators will recruit individuals (n=40) with lung cancer over a 12 month period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, 98108, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Lynn F. Reinke, PhD, ARNP
- Organization
- VA Puget Sound Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Lynn F. Reinke, PhD ARNP
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2013
First Posted
June 21, 2013
Study Start
February 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
January 31, 2017
Results First Posted
January 31, 2017
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share